Asahi Kasei Life Science Corp.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40021852

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

25/09/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%
2015 (année de référence)FY2030
Description complète des objectifs

Near-Term Targets: Asahi Kasei Life Science Corp. commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from a FY2023 base year. Asahi Kasei Life Science Corp. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, waste generated in operations, and end-of-life treatment of sold products 25% within the same timeframe. Asahi Kasei Life Science Corp. further commits that 60% of its suppliers by emissions, covering upstream transportation and distribution, will have science-based targets by FY2030.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques